anti-Orosomucoid 2 (ORM2) Anticorps

Pig (Porcine) Orosomucoid 2 (ORM2) interaction partners

1. data support the consideration that alpha-1 acid glycoprotein (Montrer ORM1 Anticorps) is a negative acute-phase reactant and appears to be regulated by cytokines

2. Data suggest that AGP/ORM1 (Montrer ORM1 Anticorps) level in blood at birth is reflective of growth conditions in utero or fetal maturation and may serve as an early predictive biomarker for pre-weaning growth rate.

3. Data indicate decreases in serum alpha-1 acid glycoprotein (Montrer ORM1 Anticorps) concentration and in hepatic ORM1 (Montrer ORM1 Anticorps) expression during the acute phase response.

4. expression of ORM1 (Montrer ORM1 Anticorps) mRNA in liver, adipose tissue well as the serum concentration of ORM (Montrer ORM1 Anticorps) protein in three porcine obesity models; the domestic pig, Gottingen minipigs and Ossabaw minipigs

5. This study suggested closer links between the release of haptoglobin (Montrer HP Anticorps), Pig-MAP and monocytes compared to the release of AGP, SAA (Montrer SAA1 Anticorps) and transthyretin (Montrer TTR Anticorps).

Human Orosomucoid 2 (ORM2) interaction partners

1. Studies suggest plasma alpha-1-acid glycoprotein (Montrer ORM1 Anticorps) (AAG (Montrer MPG Anticorps)) as a potential predictive biomarker of docetaxel non-haematological AEs (Montrer AES Anticorps) namely oral mucositis and rash.

2. the glycosylation change of alpha-1-acid glycoprotein (AGP (Montrer ORM1 Anticorps)) in hepatocellular carcinoma (HCC (Montrer FAM126A Anticorps)), cirrhosis and controls

3. Neural cell interactions are important for brain physiology and pathology. Particularly, the interaction between non-neuronal cells plays a central role in regulating brain inflammation, which is closely linked to many brain disorders. Here, we newly identified orosomucoid-2 (ORM2) as an endogenous protein that mediates such non-neuronal glial cell interactions

4. Low ORM2 expression is associated with metastasis in hepatocellular carcinoma.

5. Data suggest that human serum albumin (HSA) might serve as a carrier in delivering chitooligomers to target tissues than alpha-1-glycoprotein (AGP) which has pharmacological importance.

6. Identify ORM (Montrer ATP5A1 Anticorps) genetic variations/haplotype structure associated with serum alpha-1-acid glycoprotein (Montrer ORM1 Anticorps) level and the pharmacokinetics of paclitaxel in Japanese cancer patients.

7. Data indicate that the band intensity of sialic acid content in alpha-1 Acid glycoprotein (AGP (Montrer ORM1 Anticorps)) of alcoholic liver cirrhosis was found to be lower than that in pooled control group.

8. These findings suggest that the ORM (Montrer ATP5A1 Anticorps) distal promoter region differentially regulates expression of ORM (Montrer ATP5A1 Anticorps) genes at basal level and in acute phase responses.

9. Alteration in expression of ORM2 suggests that ORM2 could be used as a potential biomarker in the diagnosis of colorectal cancer.

10. Characterized are more than 150 human Alpha-1-acid glycoprotein (Montrer ORM1 Anticorps) isoforms, differing both in the amino acid sequence and in the glycosylation.